Holistic Health Show with Carl Helvie logoA new study published in the journal Science Translational Medicine concluded that high dose vitamin C administered intravenously with traditional chemotherapy, helped kill cancer cells while reducing the toxic effects of chemotherapy for ovarian cancer based upon studies with cells, animals and humans. Although traditional medicine stopped using high dose vitamin C after finding oral administration ineffective in two clinical trials whereas alternative medicine continued using it . The researchers said ” What we have discovered is that, because of its pharmacokinetic differences, intravenous vitamin C as opposed to oral vitamin C, kills some cancer cells without harming normal cells.”

The clinical trial involved 27 patients with newly diagnosed Stage 3 or 4 ovarian cancer. All received conventional therapy with paclitaxel or carboplatin and some were also treated with high-dose intravenous vitamin C. Participants were followed for 5 years and those receiving the vitamin C tended to experience lower toxic effects from the chemotherapy drugs. In laboratory rodents, researchers found that vitamin C killed cancer cells at the concentration achievable only by intravenous infusion, with no observable toxicity or pathological changes in the liver, kidney or spleen. More research is planned based upon these results and the researchers said “our data provide strong evidence to justify larger anbd robust clinical trials to definitely examine the benefits of adding vitamin C to conventional chemotherapy.”